Myriad Genetics Inc (NAS:MYGN)
$ 26.84 0.45 (1.71%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Q3 2022 Myriad Genetics Inc Earnings Call Transcript

Nov 01, 2022 / 08:30PM GMT
Release Date Price: $17.5 (-15.62%)
Operator

Greetings, and welcome to the Myriad Genetics Third Quarter 2022 Financial Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded today, Tuesday, November 1, 2022.

I would now like to turn the conference over to Matt Scalo. Please go ahead.

Unidentified Company Representative

Thanks, Grant, and good afternoon, and welcome to Myriad Genetics Third Quarter 2022 Earnings Call.

During the call, we will review the financial results we released today, and afterwards, we'll host a Q&A session. Our quarterly earnings release was issued this morning from -- in Form 8-K and can be found on our website at investor.myriad.com.

I'm Matt Scalo, Senior Vice President of Investor Relations. And on the call with me today is Paul Diaz, our President and Chief Executive Officer; Bryan Riggsbee, our Chief Financial Officer; and Nicole Lambert, our Chief Operating Officer.

This call will be heard via -- live via webcast at investor.myriad.com, and a recording will be archived in the Investors section of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot